期刊文献+

阿维A联合环孢素治疗红皮病型银屑病并发外源性库欣综合征1例 被引量:1

Combination Therapy with Acitretin and Cyclosporin A in a Patient with Erythrodermic Psoriasis and Exogenous Cushing Syndrome
下载PDF
导出
摘要 患者男,18岁。全身红斑、鳞屑10余年,加重4年,组织病理符合银屑病。有长期服用糖皮质激素类药物史,继发外源性库欣综合征。治疗方面,逐渐减停激素类药物,将氢化可的松由10mg 2次/d口服经半年时间逐渐减停。予阿维A 20mg 2次/d口服2个月后,减量至30mg 1次/d口服8个月至今。服用阿维A 7个月时,为加强疗效、辅助撤退激素、防止复发,加用环孢素软胶囊50mg 2次/d口服2个月,后减量为25mg 3次/d口服两周。经10个月治疗后,患者库欣综合征表现及全身皮损改善明显。从本例可以看出,长周期应用阿维A对于红皮病型银屑病并发外源性库欣综合征患者,在辅助撤退激素和改善全身皮损方面疗效肯定。对于急需控制病情和需要减停激素的患者,可考虑使用联合疗法。 An 18-year-old male patient was diagnosed with erythrodermic psoriasis,with a complaint of diffuse erythema and superficial exfoliation involving most of the body surface area for over ten years and exacerbation for four years. Histopathologic examination confirmed the diagnosis of psoriasis. A long time use of hydrocortisone induced exogenous Cushing syndrome. The hydrocortisone was gradually suspended from 10 mg bid in half a year. The patient has been treated with acitretin 20 mg bid for two months and then 30 mg qd for eight months until now. To enhance the therapy,assist in suspending hydrocortisone and prevent relapse,we added cyclosporin A 50 mg bid for two months and then 25 mg tid for two weeks three months ago. After the tenmonth treatment of acitretin and cyclosporin A,both the symptoms of Cushing syndrome and the skin lesions were improved remarkably. From this case,we conclude that long-period acitretin using may have certain effect for patients with erythrodermic psoriasis and exogenous Cushing syndrome to improve skin lesions and help suspending glucocorticoids. Combination therapy can be considered for the patients who are in urgent need of disease control and suspending glucocorticoids.
出处 《中国皮肤性病学杂志》 CAS CSCD 北大核心 2016年第3期328-330,共3页 The Chinese Journal of Dermatovenereology
关键词 红皮病型银屑病 库欣综合征 阿维A 环孢素 组织病理 Erythrodermic Psoriasis Exogenous cushing syndrome Acitretin Cyclosporin A Histopathology
  • 相关文献

参考文献11

  • 1晋红中编..皮肤病与性病学[M].北京:中国协和医科大学出版社,2011:268.
  • 2Rosenbach M, Hsu S, Korman N J, et al. Treatment of erythrodermic psoriasis: from the medical board of the National Psoriasis Foundation [ J ]. J Am AcadDermatol, 2010, 62 ( 4 ) :655 - 662. 被引量:1
  • 3Stinco G, Errichetti E. Erythrodermic psoria- sis: current and future role of biological [J]. BioDrugs, 2015,29(2) :91 - 101. 被引量:1
  • 4Pouialhon N, Begon E, Lebbe C, et al. A follow-up study in 28 patients treated with infiiximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity [ J ]. Br J Dermatol, 2007,156(2) :329-336. 被引量:1
  • 5王涛,晋红中.红皮病性银屑病的循证医学治疗[J].协和医学杂志,2012,3(4):462-465. 被引量:2
  • 6张学军.皮肤性病学[M].北京:人民卫生出版社,2011:115-117. 被引量:16
  • 7冯素英,林麟,靳培英.维A酸类药的临床应用、不良反应及对策[J].中华皮肤科杂志,2003,36(8):485-486. 被引量:99
  • 8Iebwohl M, Menter A, Koo J, et al. Combi- nation therapy to treat moderate to severe psoriasis [ J ]. J Am Acad Dermatol, 2004, 50( 3 ) :416 -430. 被引量:1
  • 9姚树兰,朱红,刘梅,孙玉鲁,杨振海,何春涤.红皮病型银屑病120例临床分析[J].中国皮肤性病学杂志,2011,25(10):764-765. 被引量:34
  • 10Brechtel B, Wellenreuther U, Toppe E, et al. Combination of etretinate with cyelospo- fine in the treatment of severe reea|eitran! psoriasis [ J ]. J Am Acad Dermatol, 1994, 30(6) : 1023 - 1024. 被引量:1

二级参考文献36

  • 1王冬云,葛文娱,刘平,王永贤,彭振辉,谭升顺.窄谱UVB联合阿维A酸治疗红皮病型银屑病[J].实用医学杂志,2005,21(13):1453-1454. 被引量:9
  • 2何玉清,张锡宝,曾抗,吴志华,罗权,黄振明,陈绍谦.阿维A与甲氨蝶呤治疗泛发性脓疱型和红皮病型银屑病的疗效及安全性评价[J].岭南皮肤性病科杂志,2006,13(1):13-16. 被引量:17
  • 3Boyd AS, Menter A. Erythrodermic psoriasis: precipitating factors, course, and prognosis in 50 patients [ J ]. J Am Acad Dermatol, 1989,21 (SPt1) :985 -991. 被引量:1
  • 4Marks J. Erythrodermas and uric acid aberrations in psoriasis [ A ]. In : Farber EM, Cox A J, editors. Psoriasis : proceedings of the international symposium [ M]. Stanford : Stanford University Press, 1971 : 89 - 98. 被引量:1
  • 5Rosenbach M, Hsu S, Korman NJ, et al. Treatment of erythrodermic psoriasis :From the medical board of the National Psoriasis Foundation [ J]. J Am Acad Dermatol,2010,62 (4) :655 - 662. 被引量:1
  • 6Haustein UF, Rytter M. Methotrexate in psoriasis: 26 years' experience with low-dose long-term treatment [ J ]. J Eur Acad Dermatol Venereol, 2000,14(5) :382 -388. 被引量:1
  • 7Studio Italiano Multicentfico nella Psoriasi (SIMPSO). Management of erythrodermic psoriasis with low-dose cyclosporine [ J ]. Dermatology, 1993,187 ( 1 ) :30 - 37. 被引量:1
  • 8Poulalhon N,Begon E,Lebbe C,et al. A follow-up study in 28 patients treated with infliximab for severer ecalcitrant psoriasis : evidence for efficacy and high incidence of biological autoimmunity[ J]. BrJ Dermatol, 2007,156(2) :329 -336. 被引量:1
  • 9Takahashi MD, Castro LG, Romiti R. Infliximab, as sole or combined therapy,induces rapid clearing of erythrodermic psoriasis[ J]. Br J Dermatol,2007,157 (4) : 828 - 831. 被引量:1
  • 10Rosenbach M,Hsu S,Korman NJ. Treatment of erythrodermic psoriasis:from the medical board of the National Psoriasis Foundation[J].Journal of the American Academy of Dermatology,2010.655-662. 被引量:1

共引文献147

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部